GILD
Gilead Sciences Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Gilead Sciences, Inc. is a leading biopharmaceutical company based in Foster City, California, renowned for its pioneering advancements in antiviral therapeutics, especially for HIV and hepatitis. The company's innovative treatments, such as Harvoni and Sovaldi, have fundamentally transformed the ma...
$150.03
+0.73% (+$1.08)
Volume
7.18M
52W High
$157.29
52W Low
$91.45
Market Cap
$188.21B
What to Watch This Quarter
Based on historical dataConsensus EPS
$2.00
Whisper EPS
$2.09
4.6% above consensus
Last Quarter
$1.86
Current Streak
1 Meet
Avg Surprise (4Q)
+7.71%
Next Earnings Report
Reports in 49 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 10, 2026
1-Day:
+5.82%
Q3 2025
Oct 30, 2025
1-Day:
+1.14%
5-Day:
+3.85%
Q2 2025
Aug 7, 2025
1-Day:
+8.28%
5-Day:
+8.83%
Q1 2025
May 8, 2025
1-Day:
-1.27%
5-Day:
+3.33%
Revenue & Financial Performance
Revenue Whisper
$7.54B
TWN Proprietary Estimate
Last Quarter Revenue
$7.93B
+4.7% YoY
Gross Margin
86.8%
Net Margin: 27.6%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $7.93B | +4.7% | 86.8% | 37.4% | $2.18B |
| Q3'25 | $7.77B | +3.0% | 79.8% | 42.8% | $3.05B |
| Q2'25 | $7.08B | +1.8% | 78.8% | 34.9% | $1.96B |
| Q1'25 | $6.67B | -0.3% | 76.9% | 33.6% | $1.32B |
| Q4'24 | $7.57B | +6.4% | 79.1% | 32.4% | $1.78B |
| Q3'24 | $7.55B | +7.0% | 79.1% | 11.8% | $1.25B |
| Q2'24 | $6.95B | +5.4% | 77.8% | 38.0% | $1.61B |
| Q1'24 | $6.69B | +5.3% | 76.8% | -64.6% | -$4.17B |
Company Information
Symbol
GILD
Company
Gilead Sciences Inc
Market Cap
$188.21B
Sector
HEALTHCARE
Next Earnings
Apr 23, 2026
Also Reporting Soon
Companies reporting earnings around the same time as GILD
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare GILD with competitors
Side-by-side earnings comparison